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Abdominal obesity and insulin resistance (IR) place youth at higher risk for premature cardiovascular disease (CVD),
but the underlying mechanisms are not clear. In adults, abdominal obesity and IR contribute to the oxidation of
low-density lipoprotein (LDL). Whether similar mechanisms are operational in Latino adolescents is unknown.
Therefore, we determined whether IR and abdominal adiposity are associated with higher oxLDL concentrations in
Latino adolescents. Data from 123 Latino adolescents (16.3 ± 2.5 years; female = 74) were used for the present
analysis. Participants were assessed for waist circumference, fasting serum oxLDL, and insulin sensitivity by the
whole body insulin sensitivity index. In separate linear regression models adjusting for age and sex, both waist
circumference and insulin sensitivity were significant predictors of oxLDL (β = 1.9; p = 0.002; R2 = 0.13, β = −1.7;
p = 0.006; R2 = 0.11, respectively). When insulin sensitivity and waist circumference were included in the same
model, both remained independent predictors of oxLDL (β = 1.7; p = 0.016 and, β = −1.5; p = 0.055, respectively;
R2 = 0.16). These results suggest that insulin resistance and abdominal adiposity are associated with higher levels
of LDL oxidation which may be a mechanism contributing to increased CVD risk in Latino adolescents.
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Obese youth are at increased risk for premature cardio-
vascular disease (CVD), and insulin resistance (IR) is
thought to be a key pathophysiologic process underlying
this risk [1]. However, the mechanisms linking obesity
and IR to elevated CVD risk in youth are unclear [2,3].
A major challenge to understanding cardiovascular health
in youth is the long latent period between elevated
CVD risk and future cardiovascular outcomes. Given
that the atherosclerotic process begins in childhood [4],
this period offers a window of opportunity for examin-
ing the initial processes that contribute to CVD risk.
Furthermore, the burden of CVD risk among adoles-
cents is of growing concern, with a large number of ad-
olescents presenting with multiple risk factors for CVD,
regardless of body weight [5]. Therefore, of emerging* Correspondence: Gabriel.Shaibi@asu.edu
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reproduction in any medium, provided the orinterest in pediatric CVD research is the use of circulat-
ing biomarkers that may aid in the stratification of risk
and in understanding the mechanisms which contribute
to CVD development [2].
Circulating oxidized low-density lipoprotein (oxLDL), a
marker of oxidative stress, is one such biomarker. In
adults, higher oxLDL is associated with acute coronary
symptoms and coronary artery disease, and it may aid in
prediction of future CVD events [6-8]. In children and ad-
olescents, oxLDL is associated with both obesity and IR
[9-11]. However, it is unclear whether these associations
are independent of each other, with one study showing in-
sulin resistance is associated with oxLDL but not inde-
pendent of obesity as defined by BMI [10], while another
study showed insulin resistance is associated with oxLDL
independent of body fatness [9]. Moreover, whether these
associations are applicable to Latino adolescents, a popu-
lation at increased risk for CVD [12], is unknown. There-
fore the objective of this study was to determine the
independent associations between IR, abdominal adipos-
ity, and oxLDL levels in Latino adolescents.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Participants and study design
Data from 123, non-diabetic, Latino adolescents (16.3 ±
2.5 yr old; 74 female) participating in the Arizona Insulin
Resistance Registry [13] were used for the present ana-
lysis. Details of the study’s purpose and methodology
have been presented elsewhere [13]. Briefly, The Arizona
Insulin Resistance Registry is an infrastructure project to
support obesity-related research among Latinos. Partici-
pants were recruited from the community and were
comprehensively phenotyped for cardiometabolic disease
risk factors (e.g. Insulin Resistance, hypertension, dyslip-
idemia, hypertriglyceridemia). In addition, participants
provided consent for banking serum to facilitate future
research such as the present study. The Arizona State
University Institutional Review Board approved the
study. All participants, along with a parent/guardian,
provided written informed consent prior to enrollment.
Participants arrived at the Arizona State University
Clinical Research Unit after an overnight fast (>10 hr).
Anthropometric measurements were taken in triplicate
and include height (to nearest 0.1 cm), weight (to near-
est 0.1 kg), waist circumference (at the umbilicus) and
body-mass index (BMI) was calculated. A fasting blood
sample (~20 mL) was taken to measure blood glucose
(FBG), insulin, total cholesterol (TC), LDL cholesterol
(LDL-c), HDL cholesterol (HDL-c), triglycerides (TG),
and oxLDL. In addition to fasting measures, participants
completed a standardized 2-hr oral glucose tolerance
test (OGTT) with blood collected at 0, 30, 60, 90, and
120 min for determination of plasma glucose and insulin
concentrations. Insulin sensitivity was estimated using
the whole-body insulin sensitivity index of Matsuda and
DeFronzo [14].
Sample analysis
The concentrations of TC, LDL-c, HDL-c, and TG were
determined using serum samples via an automated
analyzer (Cobas c 111; Roche Diagnostics; Indianapolis,
IN). Serum samples were used to measure oxLDL via
enzyme-linked immunosorbent assay (ELISA) (Merco-
dia, Winston-Salem, NC) with an inter- and intra-assay
coefficient of variation of 5.5-7.2% and 4.0-6.2%, respect-
ively. Plasma glucose was measured by the glucose oxi-
dase method using YSI 2300 STAT plus (YSI, Inc.,
Yellow Springs, OH). Insulin was measured by ELISA
(ALPCO, Windham, NH). All samples were assayed in
duplicate.
Statistical analysis
Data were analyzed using SPSS 21.0 (IBM,Armonk, NY)
and are presented as means ± SD. Non-normal data were
log base 10 transformed. Independent sample t-tests and
x2 were used to determine overall effect of weight-status(lean versus overweight/obese) on demographic, an-
thropometric, and metabolic variables of interest. Pearson
correlations were used to determine the association be-
tween waist circumference and insulin sensitivity with
oxLDL. A multivariate linear regression analysis was
used to determine the independent effect of waist
circumference or insulin sensitivity on oxLDL. These
analyses were adjusted for age and gender. Further re-
gression analysis combining waist circumference and
insulin sensitivity was used to determine the independ-
ent contribution of the variables of interest. oxLDL
concentrations were entered log base 10 transformed
for the linear regression analysis. All predictor variables
were entered non-transformed, and β values were back-
transformed for representation in tables.
Results
Table 1 shows a comparison of descriptive and cardio-
metabolic characteristics between lean (CDC-based BMI
percentile < 85th) and overweight/obese adolescents
(CDC-based BMI percentile ≥ 85th percentile). Groups
did not differ in terms of age, gender, TC, LDL-c, fasting
glucose, 2-hr glucose, and 2-hr insulin. In contrast, the
overweight/obese adolescents were taller (3.3%), heavier
(55.4%), and exhibited significantly higher waist circum-
ference (31.6%), BMI (43.0%), TG (23.9%), TG:HDL ratio
(40.0%), fasting insulin (70.1%), and significantly lower
HDL-c (12.5%) as well as insulin sensitivity (29.3%) than
their lean counterparts (all p < 0.05). oxLDL concentra-
tions were 15.2% higher in overweight/obese adolescents
compared to lean adolescents (p = 0.007). oxLDL was
significantly and positively correlated with waist circum-
ference (r = 0.34; p < 0.001) and BMI (r = 0.29; p = 0.001),
and negatively associated with insulin sensitivity (r = −0.27;
p = 0.002). Since oxLDL concentrations are influenced
by the amount of LDL particles available within circula-
tion, we further adjusted for LDL-c which did not influ-
ence the magnitude, direction, or significance of these
correlations (data not shown). Multiple linear regres-
sion analysis (Table 2) revealed that waist circumfer-
ence (β = 1.94, p = 0.002) and insulin sensitivity (β = −1.74,
p = 0.006) were significant predictors of higher oxLDL
concentrations independent of age and sex. When com-
bined for analysis (Table 2, Model 3), both waist cir-
cumference (β = 1.70, p = 0.016) and insulin sensitivity
(β = −1.49, p = 0.055) remained significant independent
predictors of oxLDL, explaining approximately 16% of
the variance.
Discussion
These findings suggest that abdominal adiposity and lower
insulin sensitivity are associated with higher oxLDL levels
in Latino adolescents. To our knowledge, this is the first
study to examine these relationships in this key and







Age 16.2 ± 2.5 16.3 ± 2.6 0.821
Gender (M/F) 21/41 33/28 0.200
Height (cm) 163.2 ± 8.3 168.7 ± 10.0 0.001
Weight (kg) 55.2 ± 8.1 85.5 ± 20.6 < 0.001
Waist circumference (cm)* 74.6 ± 6.5 98.2 ± 13.8 < 0.001
BMI (kg/m2) 20.7 ± 2.0 29.6 ± 5.5 < 0.001
BMI percentile (%) 50.3 ± 22 94.0 ± 4.9 < 0.001
TC (mg/dL)* 147 ± 31 150 ± 35 0.685
TG (mg/dL)* 88 ± 47 109 ± 53 0.022
LDL-c (mg/dL)* 88 ± 25 94 ± 30 0.313
HDL-c (mg/dL)* 48 ± 12 42 ± 10 0.003
TG:HDL ratio (mg/dL) 2.0 ± 1.3 2.8 ± 1.7 0.003
Oxidized LDL (U/L)* 38.8 ± 10.5 44.7 ± 13.9 0.007
Fasting glucose (mg/dL) 90.4 ± 5.9 90.3 ± 6.5 0.960
2-hr glucose (mg/dL) 111.3 ± 24.4 115.8 ± 24.3 0.264
Fasting insulin (μU/ml)* 7.7 ± 4.3 13.1 ± 10.1 < 0.001
2-hr insulin (μU/ml)* 65.0 ± 49.5 87.3 ± 78.3 0.087
Insulin Sensitivity index* 5.8 ± 3.1 4.1 ± 3.0 < 0.001
Data are presented are mean ± SD.
*Data was log base 10 transformed for p-value.
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[12]. These results add to the growing, but still limited,
available data on the determinants of oxLDL in children
and adolescents.
Oxidative stress occurs when the production of pro-
oxidants (i.e. OH-, O2
-) exceeds the ability of the anti-Table 2 Multiple linear regression analysis of oxidized LDL
β p-value R R2
Model 1 0.332 0.110
Age 1.45 0.065
Gender 1.58 0.023
Insulin Sensitivity Index −1.74 0.006
Model 2 0.357 0.128
Age 1.18 0.418
Gender 1.34 0.146
Waist Circumference 1.94 0.002
Model 3 0.393 0.155
Age 1.25 0.277
Gender 1.41 0.900
Insulin Sensitivity Index −1.49 0.055
Waist Circumference 1.70 0.016
DV: Log Oxidized LDL.
β values are back-transformed for interpretation.oxidant system to remove them from circulation [15].
Abdominal adiposity may contribute to oxidative stress
through visceral fat deposition and higher free-fatty acid
(FFA) flux through the portal circulation. Increased FFA
flux causes increased hepatic output of TG-rich very
low-density lipoproteins (VLDL). These TG-rich VLDL
subsequently produce a higher proportion of small, dense
LDL particles which are more readily oxidized by a num-
ber of pro-oxidants that modify apolipoprotein B and/or
the phospholipids surrounding LDL particles resulting in
oxLDL [16,17]. In addition to this mechanism, peripheral
insulin resistance is associated with mitochondrial dys-
function [18] and overproduction of pro-oxidants that can
damage or modify proteins and lipids [15]. Thus, it can be
speculated that an IR state with subsequent mitochondrial
dysfunction contributes to increased oxLDL production
through a mechanism that is independent of abdominal
adiposity. Collectively, the oxidative modification of LDL
particles to produce oxLDL is a result of an imbalance be-
tween pro- and anti-oxidants, which is exacerbated by
both abdominal adiposity and IR.
There is substantial evidence to support the direct role
oxLDL plays in atherogenesis [19]. Macrophages readily
uptake oxLDL via the scavenger receptor CD36, result-
ing in foam cell formation [17,19]. However, this occurs
in the subendothelial space, and little is known about
the impact of oxLDL in circulation or its relationship to
oxLDL within the vessel wall [17]. It has been postulated
that oxLDL exists in minimal amounts in the circulation,
which is primarily due to fully oxidized LDL being rap-
idly cleared from circulation by anti-oxidants in blood as
well as liver scavenger receptors [17,20]. Nevertheless,
even at these physiologically detectable levels, circulating
oxLDL appears to be related to CVD risk.
oxLDL has been shown to be associated with obesity and
cardiometabolic risk across the lifespan [11]. In primarily
non-Hispanic youth, Norris et al. showed that individuals
at the highest end of the BMI spectrum (i.e. extreme
pediatric obesity) exhibited higher levels of oxLDL com-
pared with normal and overweight/obese peers [10]. They
also reported a significant association between IR (as mea-
sured by HOMA-IR) and oxLDL, which was no longer sig-
nificant after adjustment for BMI. Conversely, Kelly et al.
reported a significant association between IR (as measured
by the clamp) and oxLDL that was independent of
obesity among youth [9]. It is possible that differences
in the methodologies for estimating IR explain these
seemingly disparate findings. When we re-ran our ana-
lysis using HOMA-IR, instead of the whole-body insulin
sensitivity index, HOMA-IR was not an independent pre-
dictor of oxLDL in our cohort. Collectively, these data
suggest that IR (when measured under stimulated condi-
tions) and obesity are associated with higher oxLDL,
which may result in greater CVD risk in this population.
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population of youth and the statistical consideration for
the combined influence of both abdominal adiposity and
insulin sensitivity on oxLDL. However, we acknowledge
several limitations that are worthy of comment. First, the
cross-sectional nature of the present investigation pre-
cludes any causal inferences of the present results. Second,
factors which may influence insulin resistance and CVD
risk, including pubertal maturation, maternal gestation
diabetes exposure, and family history of diabetes or CVD
were not available for the present analysis. Third, we did
not account for biochemical parameters (e.g., triglycerides)
or lifetyle factors (exercise and diet) that could influence
oxidative stress and impact oxLDL levels. Nonetheless,
our study extends the limited available science in this area,
with an application to a novel population.
In conclusion, our findings suggest that increased ab-
dominal adiposity and lower insulin sensitivity are inde-
pendently associated with higher oxLDL levels in Latino
adolescents, and may contribute to greater CVD risk in
this population. Further research is needed to determine
whether reductions in abdominal adiposity and/or im-
provements in insulin sensitivity contribute independently
or additively to improvements in circulating oxLDL and
decreased CVD risk.
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